Changes in the molecular structure of axonal and red blood cell membranes following treatment with phospholipase A2.
D000818:Animals; D001369:Axons / Q000166:cytology*; D001798:Blood Proteins / Q000032:analysis; D002462:Cell Membrane / Q000032:analysis / Q000187:drug effects*; D002942:Circular Dichroism; D003902:Detergents / Q000494:pharmacology; D004578:Electron Spin Resonance Spectroscopy; D004586:Electrophoresis; D004912:Erythrocytes / Q000032:analysis / Q000166:cytology*; D005227:Fatty Acids / Q000032:analysis; D006801:Humans; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008970:Molecular Weight; D008121:Nephropidae; D010740:Phospholipases / Q000494:pharmacology*; D010743:Phospholipids / Q000032:analysis; D011487:Protein Conformation; D012911:Snakes; D013229:Stearic Acids; D013431:Sulfates / Q000494:pharmacology; D014466:Ultraviolet Rays; D014688:Venoms
D001798:Blood Proteins; D003902:Detergents; D005227:Fatty Acids; D008244:Lysophosphatidylcholines; D010743:Phospholipids; D013229:Stearic Acids; D013431:Sulfates; D014688:Venoms; D010740:Phospholipases